z-logo
Premium
Pancreatic volume is reduced in patients with latent autoimmune diabetes in adults
Author(s) -
Lu Jun,
Hou Xuhong,
Pang Can,
Zhang Lei,
Hu Cheng,
Zhao Jungong,
Bao Yuqian,
Jia Weiping
Publication year - 2016
Publication title -
diabetes/metabolism research and reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.307
H-Index - 110
eISSN - 1520-7560
pISSN - 1520-7552
DOI - 10.1002/dmrr.2806
Subject(s) - medicine , body mass index , type 2 diabetes , diabetes mellitus , autoimmune diabetes , gastroenterology , endocrinology , type 2 diabetes mellitus , waist , type 1 diabetes
Aims This study aimed to compare pancreatic volume and its clinical significance among patients with type 2 diabetes mellitus (DM), adult‐onset type 1 DM and latent autoimmune diabetes in adults (LADA). Methods This is a cross‐sectional study. One hundred twenty‐six outpatients (68 with LADA and 58 with type 1 DM) and 158 inpatients (71 with type 2 DM and 87 non‐diabetic controls) were recruited during May–July 2013 in Shanghai Jiao Tong University Affiliated Sixth People's Hospital. All the patients underwent abdominal computerized tomography; pancreatic volume was then calculated. Results The mean pancreatic volume was highest in the controls, followed by those in patients with type 2 DM, LADA and type 1 DM. The pancreatic volume in LADA was comparable with that in type 2 DM but significantly greater than that in type 1 DM ( p  < 0.05). The pancreatic volume in patients with LADA was significantly correlated with sex, waist circumference, body surface area, body mass index, diastolic blood pressure and high‐density lipoprotein cholesterol (all p  < 0.05). The correlation between pancreatic volume and fasting C‐peptide was high in patients with LADA ( r  = 0.643, p  < 0.001) and moderate in patients with type 2 DM ( r  = 0.467, p  < 0.001). The area under the receiver operating characteristic curve for pancreatic volume predictive of absolute insulin deficiency (FCP < 0.9 ng/mL) was 0.85 (0.76–0.94) in LADA. Conclusions Pancreatic atrophy in LADA was less marked than in type 1 DM. Pancreatic atrophy may suggest reduced level of fasting C‐peptide in patients with LADA. Copyright © 2016 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom